Clinical Software in Florida

Accessibility Services, Inc. (ASI) is a Florida-based specialist in environmental control units (ECUs) and augmentative and alternative communication (AAC) devices for individuals with severe disabilities including ALS and spinal cord injuries. The company manufactures and distributes the autonoME family of products—including hospital, residential, and portable models—that enable patients to control critical hospital and home devices (beds, lights, televisions, nurse call systems, telephones) and access communication, computing, and entertainment features via sip-and-puff or other adaptive input methods. ASI serves hospitals, residential facilities, individual patients, and caregivers nationwide. The company is a federal contractor registered with SAM.gov and emphasizes personalized support and clinical integration of assistive technology.

Catalent is a global Contract Development and Manufacturing Organization (CDMO) serving pharmaceutical, biotech, consumer health, and self-care companies. Founded in 2007 and headquartered in Tampa, Florida, the company operates over 50 sites worldwide with approximately 8,500 employees. Catalent specializes in end-to-end drug development, manufacturing, and supply chain services, leveraging advanced technologies including softgel encapsulation, Zydis Ultra oral fast-dissolve systems, and proprietary molecular optimization platforms. Core service areas include oral dose forms, biologics development and manufacturing (drug substance and drug product), cell and gene therapy, specialty dose delivery (inhalation, nasal, pulmonary systems), clinical supply chain management, and self-care product development. The company provides comprehensive analytical chemistry, formulation development, bioavailability studies, regulatory support, clinical packaging, comparator sourcing, and distribution logistics. Catalent has a proven track record supporting FDA approvals and commercial product launches across multiple therapeutic areas.

Wellvii Inc. is a Palm Beach Gardens-based medical device innovator specializing in non-invasive blood pressure monitoring from the finger. The company holds 59 patents for breakthrough finger-based vital signs measurement. The FDA-cleared and CE-marked VitalDetect is the only finger-based device authorized to replace traditional arm cuff blood pressure monitors, offering superior patient comfort and compliance while eliminating need for multiple separate devices. VitalDetect captures 9 clinically validated vital signs including non-invasive blood pressure without calibration, heart rate, heart rate variability, respiration rate, SpO2, temperature, pulse pressure, perfusion index, and pleth variability index in under 2 minutes. The next-generation BP Go (launching Q2 2026) targets the home market with Cat-M1 cellular and Bluetooth connectivity for remote monitoring and data sharing. Wellvii also offers complementary monitoring devices (Temp, Go wearable, Weight scale) and a proprietary AI/predictive analytics platform (Wellvii Health Cloud) providing real-time vital sign analysis, wellness scoring, and family health management via intuitive mobile app.

Squegg Inc manufactures a medical device and connected software platform for assessment and monitoring of upper extremity functional impairments, specifically grip strength and pinch strength. The core product, Squegg, is a digital dynamometer paired with an interactive app featuring therapeutic games and exercises. The company serves occupational therapists, hand therapists, physical therapists, and clinicians in both in-person and remote care settings. Squegg PRO, the clinical management platform, enables home exercise program (HEP) assignment, remote therapeutic monitoring (RTM), longitudinal patient tracking, and compliance monitoring. The device is validated through published clinical research comparing favorably to the Jamar dynamometer, establishing grip strength as a functional biomarker for aging, disease progression, and health outcomes. Applications include post-surgical hand rehabilitation, neurorehabilitation, geriatric care, fine motor skill training, and clinical research settings. The platform supports both individual patient care workflows and population-level clinical studies with standardized, objective data collection. Products are marketed to clinicians and athletes globally, with emphasis on ease of use, hygiene, portability, and measurable functional outcomes suitable for billing and outcomes documentation.

Sun Nuclear Corporation is a global leader in radiation oncology quality assurance (QA) solutions, serving over 6,000 healthcare facilities in more than 130 countries. Founded in 1984 and headquartered in Melbourne, Florida, the company specializes in comprehensive QA platforms for radiation therapy and diagnostic imaging, with solutions deployed in over 90% of U.S. cancer treatment centers and 60% of global facilities. Sun Nuclear provides advanced dosimetry verification, machine QA, patient-specific plan verification, and AI-powered treatment planning tools. The portfolio includes proprietary detector technologies, phantom systems, and integrated software solutions designed to enhance patient safety and streamline clinical workflows. In 2021, Sun Nuclear was acquired by Mirion Technologies, strengthening its position in radiation safety innovation. The company offers extensive clinical support, training, and service backed by over 300 years of combined team expertise and 34 patents in radiation oncology and diagnostic imaging QA.

Biotech Research Group (BRG) is a full-service regulatory and product development consulting firm headquartered in Tampa, Florida. BRG specializes in expedited commercialization pathways for pharmaceutical, biologic, and medical device companies navigating FDA and global regulatory requirements. The firm maintains a global network of expert consultants across 60+ countries with specialized expertise in toxicology, pharmacokinetics, statistics, epidemiology, and pharmacovigilance. BRG's core services span biologics (BLA, tissue registrations, vaccines, gene therapy), medical devices (510(k), PMA, PMN applications, implants, surgical devices), pharmaceutical drugs (NDA, ANDA, IND, OTC), quality assurance (ISO clean room operations, audits, SOP implementation, FDA adverse event reporting), and specialty services including emergency use authorizations, expert witness testimony, and literature reviews. The firm emphasizes FDA compliance leadership, clinical research design, and quality management as keys to regulatory success, offering cost- and time-effective tailored product development plans.

Cosmereg is a regulatory compliance consultancy specializing in assisting cosmetics, dietary supplements, food, and medical device manufacturers in achieving market authorization across North America, Europe, and the Middle East. The firm provides end-to-end regulatory guidance including FDA Agent services for US market entry, Responsible Person designation for EU/UK/Canada cosmetics compliance, product classification, labeling review, facility registration, and submissions (510(k) for medical devices, CPNP for EU cosmetics, CNF for Canada cosmetics). The company serves multinational clients across 50+ countries with expertise in FDA regulations, Health Canada requirements, and European regulatory frameworks, helping manufacturers navigate complex compliance pathways and avoid delays, penalties, or product recalls.

ARC-One Solutions, LLC is a medical device software company founded in April 2020 through a partnership between the American Red Cross and OneBlood, two of the largest blood centers in the United States. The company develops next-generation Blood Establishment Computer Software (BECS) platforms designed to manage safe, efficient, and compliant blood supply chain operations. ARC-One manufactures the Regulated Software Application (RSA), a series of web-based applications that encapsulate data access and business rules for blood collection, manufacturing, labeling, distribution management, and administrative functions. RSA was originally created over 15 years ago by Community Blood Centers of Florida and obtained FDA 510(k) clearance in 2012. The software is currently deployed at OneBlood across Florida, Georgia, Alabama, and the Carolinas, supporting delivery of safe blood products to hospitals and patients. Once fully implemented, ARC-One's redesigned software suite will process approximately 10 million blood products across 56 states and territories, supporting over 50% of the nation's blood supply. The company operates under a strict FDA-regulated quality system and was developed by experienced blood banking professionals. ARC-One serves hospital blood banks, community blood centers, and blood collection facilities requiring comprehensive regulatory compliance and operational efficiency in blood supply chain management.

MonitAir is a cloud-based FDA-registered Medical Device Data System (MDDS) and HIPAA-compliant digital health platform purpose-built for sleep medicine practices. The platform delivers integrated remote patient monitoring (RPM), remote therapeutic monitoring (RTM), chronic care management (CCM), and telemedicine capabilities in a single dashboard. MonitAir automates workflows for sleep clinics by connecting seamlessly to major PAP devices (ResMed, Philips), pulse oximeters, wearables (Apple Watch, Garmin, Fitbit, Oura), and EHR systems to enable real-time patient data synchronization without manual entry. Core functionality includes CPAP adherence tracking, at-risk patient identification, AI-powered non-adherence prediction (achieving 93% accuracy by day 30), automated patient outreach, compliance reporting, and RPM billing support with CPT code documentation. The platform surfaces actionable clinical insights including compliance metrics, AHI tracking, mask leak monitoring, and wearable-derived sleep patterns, heart rate, SpO₂, and activity data. Flexible tiered pricing supports practices at all stages—from basic adherence monitoring to full RPM/RTM/CCM programs. MonitAir serves 20+ sleep clinics monitoring 6,000+ patients nationwide and is backed by Harvard Innovation Lab. The company emphasizes rapid deployment (5-minute setup), dedicated onboarding support, and clinical validation through a 196-patient randomized controlled trial demonstrating improved CPAP adherence outcomes. Regulatory status: FDA registered; HIPAA compliant with end-to-end encryption.

LGM International Inc. manufactures Liqui-PREP® cytology specimen preservation reagents and automated processing instrumentation for clinical cytology laboratories. The company specializes in liquid-based cytology preparation systems designed to streamline specimen collection, preservation, and processing workflows. Their product line includes Liqui-PREP® Reagents (non-hazmat preservation media), the Auto-LP® PRO (walk-away automated specimen processor), and the Auto-LP® Stainer (automated staining system). The reagents enable preservation of specimens immediately upon collection with simplified protocols, reducing per-slide processing time by approximately 50%. LGM International offers flexible automation solutions, allowing laboratories to process high-volume samples automatically while retaining manual processing capability for lower-volume workloads. The company holds FDA certification, EU In Vitro Diagnostic Regulation (IVDR) compliance, and ISO 13485:2016 Quality Management System registration. Products are manufactured and distributed globally. LGM International provides comprehensive training support through instructional materials, video resources, live streaming sessions, and direct technical support via email and phone. The Liqui-PREP® system emphasizes user-friendliness, cost-effectiveness, environmental safety (non-hazmat shipping and drain-safe disposal), and laboratory productivity enhancement.

Formulated Solutions is a U.S.-based Contract Development and Manufacturing Organization (CDMO) founded in 1999, specializing in the development and manufacturing of pharmaceuticals, consumer health products, medical devices, and personal care items. Operating from facilities in Largo, Florida and Cleveland, Tennessee with nearly one million square feet of production space, the company provides comprehensive end-to-end services from concept through commercial scale. Core competencies include formulation and process development, analytical testing, regulatory affairs, and innovative packaging solutions. Formulated Solutions excels in specialized dosage formats including aerosols, topicals, nasal sprays, semi-solids (creams, ointments, gels), and liquid orals. The company serves Rx therapeutics, over-the-counter consumer health, and medical device markets. With 519 employees and approximately $262.6 million in annual revenue, Formulated Solutions partners with global healthcare leaders to deliver patient-friendly, differentiated products with quality embedded throughout the development and manufacturing process.

Intelligent Retinal Imaging Systems (IRIS) develops cloud-based retinal screening software designed to identify and manage diabetic retinopathy and other retinal pathologies. The company provides a comprehensive solution combining digital retinal imaging capture, image enhancement, remote interpretation by board-certified ophthalmologists, and integration with existing electronic medical records (EMR) systems. IRIS operates a camera-agnostic platform compatible with multiple imaging devices, enabling healthcare providers to conduct preventive retinal screenings in primary care settings, federally qualified health centers (FQHCs), hospitals, health plans, pharmacies, and health risk assessment companies. The platform securely stores and manages patient information, with results delivered to providers within target timeframes. Implementation includes customized workflow integration, staff training, hardware recommendations, and ongoing technical support. The solution is designed for rapid deployment, with typical go-live in 90 days. IRIS serves diverse healthcare organizations including major health systems (Prisma Health, St. Elizabeth Physicians, LifeBridge), health insurance plans, and community care networks. The company emphasizes care gap closure for diabetic patients, reducing preventable blindness, and improving quality compliance measures. As of 2025, Intelligent Retinal Imaging Systems was acquired by Topcon Healthcare to enhance connected care across primary and eye care settings.

Sequel Med Tech develops automated insulin delivery (AID) systems for people with diabetes, primarily Type 1 diabetes. The company's flagship product is the twiist Automated Insulin Delivery System, powered by the Tidepool Loop algorithm, which automatically adjusts basal insulin delivery based on continuous glucose monitoring. Sequel addresses accessibility barriers in AID adoption by delivering affordable insulin therapy through pharmacy channels rather than traditional medical device distribution. The company serves multiple markets: healthcare providers and people with diabetes (via twiist consumer platform), employers and health plan consultants (via Sequel Connect), and pharmaceutical companies developing innovative drug delivery solutions. The twiist system features precise measurement technology for accurate insulin delivery and is designed for everyday wearability. Sequel's approach emphasizes simplified access to revolutionary diabetes management technology, with real-world evidence supporting clinically meaningful benefits. The company continues to advance diabetes care technology and explore next-generation drug delivery partnerships.

KLS Martin Group is a globally leading surgical medical technology company founded in 1896, headquartered in Mühlheim an der Donau, Germany, with a North American operation in Jacksonville, Florida. The company develops and distributes comprehensive surgical solutions including implant systems, radiofrequency surgical devices, surgical lasers, operating room lights, surgical instruments, sterilization containers, and instrument trays and storage systems. Core product lines include Individual Patient Solutions (IPS®)—customized patient-specific implants and solutions utilizing 3D printing and advanced imaging; IPS CaseDesigner®—surgical planning and simulation software; IPS Implants® Preprosthetic—subperiosteal dental implants for severe bone loss; CapFlex PIP—finger joint endoprostheses; smartOne® monopolar handles and electrodes for electrosurgery with integrated smoke evacuation; SonicWeld® bone welding systems; and comprehensive surgical instrument and sterilization container systems. The company serves maxillofacial, orthopedic, dental, cranial, and general surgery specialties. KLS Martin maintains manufacturing and development facilities in Germany with global distribution. The company emphasizes regulatory compliance, quality, and innovation across surgical disciplines, supported by service programs including marManagement (instrument audit, repair, and optimization) and training capabilities.

NeuroTrax Corp is a leading provider of medical-grade cognitive health assessment software serving clinical, research, and legal markets. The company has delivered evidence-based cognitive testing platforms for over 20 years to major institutions, hospitals, and research facilities. NeuroTrax specializes in objective measurement of cognitive function across seven major cognitive domains: attention, executive function, information processing, verbal function, attention span, visuospatial skills, and motor skills. The platform enables early detection of cognitive impairment through digital, adaptive testing administered in under one hour in clinical offices or research facilities. Clinical users benefit from CPT code reimbursability (96132, 96133, 96136, 96137, 96138, 96139, 96146) and longitudinal tracking capabilities to monitor disease progression and treatment effects. Researchers access data exports in statistics-ready formats compatible with major analysis tools and research workflows. The platform has been validated in hundreds of peer-reviewed publications in leading medical journals. NeuroTrax serves neurologists, neuropsychologists, primary care physicians, clinical specialists, researchers, and legal professionals requiring objective cognitive performance measurement. The system generates detailed, patient-friendly reports supporting clinician-directed care planning and research analysis. Administration requires only a quiet room and computer, with no specialized equipment necessary.

Ametris (formerly ActiGraph) is a digital health technology (DHT) company specializing in wearable medical devices and remote monitoring platforms for clinical research and drug development. The company provides FDA-cleared, medical-grade wearable devices paired with a scalable remote monitoring platform to capture objective, real-world patient data across multiple clinical domains. Ametris delivers an integrated, end-to-end solution combining hardware, cloud-based software, proprietary algorithms, and comprehensive operational and scientific support services. Core measurement capabilities include physical activity, gait and mobility analysis, sleep behavior monitoring, vital signs tracking, and cardinal symptom assessment. The platform is purpose-built to support all phases of the clinical trial lifecycle—from study design and site training to data collection, processing, archiving, and real-time monitoring. Ametris has established expertise in neuromuscular disorders, oncology, neuroscience, sleep medicine, and metabolic diseases. The company serves pharmaceutical sponsors, biotechnology firms, clinical research organizations (CROs), academic institutions, and hospital research networks across 150+ countries. With over 20 years of remote data capture expertise, 30,000+ peer-reviewed scientific publications supporting its technologies, and operational involvement in 285+ industry-sponsored clinical trials, Ametris positions itself as a scientific partner rather than a technology vendor alone. Services include endpoint design consultation, algorithm validation, regulatory strategy support, and DHT data interpretation. The company maintains headquarters in Pensacola, Florida, and operates a global support infrastructure with 24-hour critical support availability.

EEG Software LLC develops and delivers neurofeedback software and training for clinical and at-home use. The company's flagship product, EEGer4, is a comprehensive neurofeedback suite that enables real-time EEG monitoring, live training feedback, and data review. EEGer4 supports remote and telehealth training modalities, integrates third-party amplifiers and therapeutic games, and is used across private practices, universities, regional healthcare networks, government agencies, and home-based clients in over 20 countries and all US states. The system is non-invasive and designed to help clinicians and clients with neurofeedback-based treatment for various conditions. EEG Software LLC offers BCIA-approved introductory training courses for clinicians and healthcare professionals, delivered by experienced practitioners and supported by clinical mentors throughout implementation and practice development. The company provides premium technical support for equipment setup, troubleshooting, and ongoing clinical operations. Founded and operated as a family business in Gainesville, Florida, the organization emphasizes practitioner-focused software design, flexibility in service delivery, and community support. The EEGer user community spans thousands of clinicians and includes universities and healthcare systems. The company maintains a privacy-first policy and offers comprehensive training curricula and continuing education opportunities.

NovuTech is a medical device distributor with 35 years of experience commercializing innovative medical technologies and health & wellness products across the Americas. The company operates as a full-service distribution partner offering sales, regulatory compliance, logistics, marketing, distribution, and e-commerce capabilities. NovuTech maintains a strategic presence across 13 countries including the USA, Mexico, Brazil, Chile, Colombia, Peru, Ecuador, Bolivia, Venezuela, Dominican Republic, Guatemala, Costa Rica, Honduras, and Panama, providing localized support and efficient supply chain solutions tailored to regional healthcare market needs. The company's portfolio spans orthopedic devices (certified, high-quality products competing with leading industry brands), digital health technologies and medical technology ecosystems, and cardiology solutions (currently in development). NovuTech distributes through multiple channels including direct sales, sub-distributors, insurance companies, e-commerce, private health systems, and public health institutions. The company emphasizes regulatory compliance adherence to both local and international standards, seamless technological integration into existing healthcare infrastructure, and client-centric solutions. While specific product model numbers and FDA/regulatory certifications are not listed on the website, the company positions itself as offering reliable, high-end medical technologies designed to enhance clinical outcomes and improve patient care delivery across healthcare provider networks in the Americas.

Health Data Works develops Veristra™, an FDA Breakthrough Device software platform for dialysis access tracking and optimization. The platform provides real-time logging and visual mapping of dialysis access cannulation sites, enabling precision tracking with dynamic image records, symbolic overlays of current and prior puncture points, and heatmap visualizations to highlight high-use zones and emerging complications. Veristra™ delivers frontline decision support to technicians for optimal cannulation site selection, reducing dialysis initiation time and lowering complication risks. The platform provides patient-centered insights with comprehensive real-time visibility for the entire care team, automated oversight and analytics tracking technician activity with actionable performance reports, and collaborative integration designed for vascular access centers and interventional clinics. The system supports compliance with CMS guidelines and value-based care goals. Health Data Works operates on a capital-efficient SaaS model and is led by experienced clinicians, technologists, and healthcare entrepreneurs. The company serves dialysis centers, vascular access specialists, and interventional clinics seeking to optimize access site management and improve patient safety outcomes.

Watermark Medical is a B2B medical devices company specializing in cloud-based home sleep diagnostics for obstructive sleep apnea (OSA) detection and management. Founded in 2008 and headquartered in West Palm Beach, Florida, the company has performed over 1.3 million home sleep tests through its flagship ARES™ Home Sleep Test—a disposable, patient-friendly device paired with a virtual platform for data analysis and physician review. The company serves three primary markets: healthcare providers (physician and dental practices, clinics), direct-to-patient services through an accredited independent diagnostic facility, and enterprise clients (employers, institutions, benefit managers) seeking population health sleep solutions. Watermark's cloud-based platform streamlines diagnostic workflows, reduces testing costs relative to traditional in-lab polysomnography, and delivers 96% clinical correlation to laboratory PSG with a documented 1% device failure rate. All tests undergo clinical review by trained sleep technicians and physician oversight. The company maintains a network of 400+ interpreting sleep physicians and serves 75,000+ healthcare providers.

Jabbla develops augmentative and alternative communication (AAC) software and devices for individuals who cannot speak or have difficulty speaking. The company manufactures dedicated AAC communication devices (Allora 3, Vibe 10, Vibe 12+, Tellus 6/i6, Hey_) featuring customizable access methods including touch screen, joystick, switches, head tracking, and eye tracking. Core software offering is Mind Express, a comprehensive communication platform enabling users to generate speech, send emails and text messages, control environmental systems, and expand language skills. The company also provides SprintPlus software and ready-made vocabulary page sets (AlphaCore, Amego, Gateway, PODD, SCORE, Steps to language) designed from scientific and practical insights for pediatric and adult populations. Devices are wheelchair-accessible and support remote communication via standard messaging platforms. The company serves speech-language pathologists, rehabilitation centers, schools, and families. No regulatory certifications (FDA, CE, ISO) are explicitly mentioned on the site. Jabbla is headquartered in Ghent, Belgium, with multilingual support (English, Dutch, French). Support and training services are available.

MRS Health, Inc. is an AI-enabled population health management company specializing in musculoskeletal disorder (MSD) prevention, diagnosis, and treatment. The organization delivers an integrated care program combining predictive analytics, functional restoration therapy, and connected home rehabilitation devices. MRS Health uses proprietary algorithms and supervised learning AI to identify at-risk populations from medical and pharmacy claims data, enabling early intervention and cost mitigation. The company operates center-based functional restoration programs staffed by physicians, physical therapists, exercise physiologists, and health coaches, utilizing biomechanically optimized equipment and IT platforms. For distributed workforces, MRS Health provides telehealth-enabled connected strengthening devices for spine, back, and neck rehabilitation—devices designed for home use that deliver clinically proven outcomes. The company targets leading healthcare cost drivers including musculoskeletal conditions, opioid use disorder, mental health, diabetes, and durable medical equipment expenses, with demonstrated ROI exceeding 3.5:1 for employer-sponsored health plans.

XRD Dental Equipment is a Florida-based dental equipment manufacturer and service provider with 45+ years of industry experience. The company manufactures and distributes the XRD 70 portable dental X-ray system (FDA 510(k) cleared, 70 kV, Canon D-045 Japanese tube, 0.4 mm focal spot), XRD Imagen intraoral digital sensors for radiographic imaging, ArchiMED Suite 5 multiplatform imaging software for dental and veterinary imaging (with 3D capability), and the STE23 Class B steam sterilizer for dental instrument processing. XRD also provides in-house repair services for dental portable X-ray equipment, including XRD portables, Digital Doc XTG, and Digimed systems, with diagnostic testing capabilities (kVp, mA, HVL, leakage evaluation). The company operates a service facility in Clermont, FL, and offers nationwide shipping with fast turnaround times. Service offerings include extended warranty plans (5-Year Extended Warranty and Ultra Care annual plans with loaner unit coverage) and the XRD Care Club, an equipment-as-a-service membership program (currently Florida only) that provides the XRD 70 with monthly subscription, warranty inclusion, and 5-year equipment refresh cycles. All equipment is FDA-registered. The company serves dental practices, veterinary clinics, and hospitals with a focus on reliability, professional support, and customer service.

Florida Probe Corporation is an industry leader in computerized probing and periodontal charting systems for dental professionals. Since 1987, the company has provided innovative diagnostic and monitoring solutions for all stages of periodontal disease. The flagship Florida Probe System features a computerized handpiece (probe) invented at the University of Florida and FDA-approved for measuring pocket depths and clinical attachment levels. The company offers advanced software solutions including FP32 Version 9 with digital signature capture, SQL database management, wireless keypad support (GoProbe System), and voice-activated charting (VoiceWorks). Products include reusable and disposable probes, periodontal charting software with practice management integration, patient education tools, and continuing education courses for dental hygienists and practitioners.

Surgical Resources Group, LLC is a B2B surgical supply distributor and healthcare solutions provider based in Clearwater, Florida. The company specializes in cost-recovery and cost-savings solutions on high-volume surgical devices, offering discounted pricing on thousands of surgical items from over 30 manufacturers. SRG's core business includes wholesale distribution of surgical supplies with no minimum orders, flexible payment terms, and overnight to ground shipping options. Product subspecialties encompass endo-mechanicals, energy devices, fixation devices, OB/GYN devices, hernia mesh, orthopedic implants, sports medicine devices, urology supplies, wound care products, and bariatric surgery instruments. Beyond traditional surgical supply distribution, SRG provides business solutions including SupplyAssist (mobile device barcode scanning applications) and managed IT services for healthcare facilities. The company emphasizes inventory management and team development services. SRG is a member of the USF Health LIFT Community and maintains partnerships with nonprofits including Advocates for World Health (AWH) and Ssubi, focusing on medical supply sustainability and global healthcare access. The company holds a BBB accreditation and offers flexible ordering through phone, fax, email, and online channels. Products are available by individual units, boxes, and cases with guaranteed low prices and bulk order discounts.

HIZIR LLC is a dental manufacturing and 3D printing service provider specializing in metal additive manufacturing for dental laboratories and prosthodontists. The company manufactures and operates metal 3D printing systems (Space Ti-160 printer) capable of processing titanium alloys and cobalt-chrome materials, complemented by post-treatment equipment including annealing tube furnaces and plasma polishing machines. Core capabilities include full-service dental laboratory manufacturing with CAD design services, metal crown fabrication (gold and non-precious options), titanium and zirconia custom abutments, implant components, frameworks (Co-Cr, titanium, thermoflex), acrylic and flexible partial dentures, porcelain-fused-to-metal restorations, full ceramic/zirconia crowns, and orthodontic appliances. The company offers both equipment sales and comprehensive outsourced manufacturing services with typical turnaround of 10 business days. Materials include proprietary HIZIR-branded titanium alloy and cobalt-chrome powders. Services span design-only options through finished product delivery. The company positions itself as a vertically integrated manufacturer, controlling both equipment production and material supply to manage quality and cost. Target market is dental laboratories, implant centers, and prosthodontic practices in North America.

SHL Medical is a global leader in the design, development, and manufacturing of self-injection drug delivery devices, including autoinjectors and pen injectors. The company serves pharmaceutical and biotechnology partners by providing end-to-end solutions spanning feasibility assessment, device design, development, scale-up, production, and final assembly with labeling and packaging services. SHL Medical's product portfolio includes the Molly series (1.0, 2.25), Maggie series (3.0, 5.0), Reunite, Quanta pen injector, and Elexy innovation platform. The company specializes in enabling patients with chronic conditions such as diabetes and lupus to self-administer injectable treatments, thereby improving treatment outcomes and reducing healthcare system costs. With over 6,000 employees across multiple global locations (Switzerland, Taiwan, Sweden, and the United States), SHL Medical operates manufacturing and R&D facilities that support advanced drug delivery innovation. The company provides device support services, advanced manufacturing solutions, and alliance partnerships with pharmaceutical companies. SHL Medical maintains regulatory compliance standards required for medical device manufacturing and distribution.

Smart Meter LLC is a leading remote patient monitoring (RPM) technology and solutions provider headquartered in Tampa, Florida. The company specializes in cellular-enabled personal health monitoring devices and cloud-based platforms designed for RPM and chronic care management (CCM) programs. Smart Meter manufactures and distributes FDA-approved, multi-carrier SIM cellular devices including glucose monitors (iGlucose Plus), blood pressure monitors (iBloodPressure, iBP Classic), pulse oximeters (iPulseOx), and weight scales (iScale). All devices transmit readings directly via 4G/5G cellular networks with no hub, Bluetooth pairing, or WiFi required. The company operates a proprietary private data network developed in collaboration with AT&T, providing multiple layers of HIPAA-compliant data security. Smart Meter's platform includes patient engagement tools (Smart Touch®), comprehensive data analytics dashboards, device management portals, and performance reporting. The company manages over 315,000 patients for 800+ RPM partners including healthcare providers, RPM platforms, and software integrators. Additional services include world-class logistics with same-day shipping for orders placed by 1 PM ET, Tier 1/Tier 2 technical support, and dedicated client success management. Regulatory compliance includes FDA approval, HIPAA, FTC, Medicare, and commercial payor requirements. The company processes 3+ billion data points annually and ships 1+ million orders annually.

Sigma Biomedical is a medical technology development and consulting firm headquartered in Hialeah, Florida, with roots in biomedical research at Germany's Fraunhofer Institute. The company specializes in FDA regulatory consulting, medical device compliance, product safety and performance testing, and quality management system implementation. Sigma assists manufacturers and academic institutions navigating US and international medical device regulations, including 510(k) premarket notifications, device classification, and compliance with 21 CFR 820 (cGMP) and ISO 13485 standards. The firm offers comprehensive support for medical device registration, product testing validation against FDA-recognized consensus standards, GAP analysis for quality systems, and regulatory training programs. Sigma also provides cloud-based medical informatics and telemedicine solutions in select Latin American markets to improve healthcare access and operational efficiency.

C-RAD is a global medical device company specializing in Surface Guided Radiation Therapy (SGRT) solutions for cancer treatment. The company develops and manufactures patient-centric, user-friendly positioning and guidance systems that enable precise radiotherapy treatments and improve clinical outcomes in oncology. C-RAD's primary product lines include the Catalyst+ platform (available in HD, LITE, PT, and HD Ring Gantry configurations), the Sentinel 4DCT system for 4D imaging during treatment, cAutoVerify automated verification software, and Visual Coaching Solutions for patient guidance. These systems deliver real-time surface imaging and tracking to ensure treatment accuracy, reduce setup errors, and enhance workflow efficiency in radiation therapy departments. The company serves cancer treatment centers, hospitals, and clinics globally through direct sales offices in Sweden, Germany, France, USA, Australia, China, and India, as well as through regional distributors. C-RAD emphasizes interoperability with existing linear accelerators and treatment planning systems, system reliability, ease of use, and comprehensive technical support. The company maintains global service support groups for installation, clinical implementation, preventive maintenance, and software upgrades throughout the product lifecycle.